Cinctive Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-39,816
Closed -$9.22M 385
2025
Q3
$9.22M Buy
39,816
+9,956
+33% +$2.03M 0.44% 66
2025
Q2
$5.54M Buy
29,860
+26,324
+744% +$4.89M 0.29% 113
2025
Q1
$741K Buy
+3,536
New +$687K 0.06% 235
2024
Q2
Sell
-25,485
Closed -$4.64M 383
2024
Q1
$4.64M Buy
25,485
+15,613
+158% +$2.69M 0.22% 136
2023
Q4
$1.53M Buy
+9,872
New +$1.44M 0.1% 209
2022
Q1
Sell
-102,727
Closed -$14.9M 497
2021
Q4
$13.9M Sell
102,727
-32,700
-24% -$3.86M 0.61% 26
2021
Q3
$14.6M Sell
135,427
-8,327
-6% -$951K 0.72% 18
2021
Q2
$16.2M Buy
143,754
+7,428
+5% +$837K 0.76% 11
2021
Q1
$14.8M Buy
136,326
+24,061
+21% +$2.57M 0.9% 9
2020
Q4
$12M Sell
112,265
-18,940
-14% -$1.82M 0.98% 10
2020
Q3
$11.5M Buy
131,205
+43,648
+50% +$4.11M 1.01% 7
2020
Q2
$8.6M Buy
87,557
+18,932
+28% +$1.67M 0.99% 8
2020
Q1
$5.23M Sell
68,625
-12,375
-15% -$1.05M 1.16% 15
2019
Q4
$7.17M Buy
+81,000
New +$6.72M 0.75% 34

Other funds holding ABBV

Cinctive Capital Management's ABBV Position: Q4 2025 in Review

Cinctive Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 39,816 shares — an estimated $9.22M sold.

Cinctive Capital Management first reported a position in ABBV in Q4 2019 and held it in 14 quarters. The position peaked at $16.2M in Q2 2021. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Cinctive Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 39,816 AbbVie shares in Q4 2025, an estimated $9.22M.
  • Cinctive Capital Management first reported a position in AbbVie in Q4 2019 and held it in 14 quarters.
  • Cinctive Capital Management's AbbVie position peaked at $16.2M in Q2 2021.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.